Abstract
| Language | English |
|---|---|
| Pages | 641-648 |
| Journal | AIDS Research and Human Retroviruses |
| Volume | 28 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 2012 |
Fingerprint
Cite this
}
Measurements of immune responses for establishing correlates of vaccine protection against HIV. / Burgers, WA; Manrique, A; Masopust, D; McKinnon, LR; Reynolds, MR; Rolland, M; Blish, C; Chege, GK; Curran, Rhonda M; Fischer, W; Herrera, C; Sather, N.
In: AIDS Research and Human Retroviruses, Vol. 28, No. 7, 2012, p. 641-648.Research output: Contribution to journal › Article
TY - JOUR
T1 - Measurements of immune responses for establishing correlates of vaccine protection against HIV
AU - Burgers, WA
AU - Manrique, A
AU - Masopust, D
AU - McKinnon, LR
AU - Reynolds, MR
AU - Rolland, M
AU - Blish, C
AU - Chege, GK
AU - Curran, Rhonda M
AU - Fischer, W
AU - Herrera, C
AU - Sather, N
PY - 2012
Y1 - 2012
N2 - Well-defined correlates of protective immunity are an essential component of rational vaccine development. Despite years of basic science and three HIV vaccine efficacy trials, correlates of immunological protection from HIV infection remain undefined. In December 2010, a meeting of scientists engaged in basic and translational work toward developing HIV-1 vaccines was convened. The goal of this meeting was to discuss current opportunities and optimal approaches for defining correlates of protection, both for ongoing and future HIV-1 vaccine candidates; specific efforts were made to engage young scientists. We discuss here the highlights from the meeting regarding the progress made and the way forward for a protective HIV-1 vaccine.
AB - Well-defined correlates of protective immunity are an essential component of rational vaccine development. Despite years of basic science and three HIV vaccine efficacy trials, correlates of immunological protection from HIV infection remain undefined. In December 2010, a meeting of scientists engaged in basic and translational work toward developing HIV-1 vaccines was convened. The goal of this meeting was to discuss current opportunities and optimal approaches for defining correlates of protection, both for ongoing and future HIV-1 vaccine candidates; specific efforts were made to engage young scientists. We discuss here the highlights from the meeting regarding the progress made and the way forward for a protective HIV-1 vaccine.
U2 - 10.1089/aid.2011.0239
DO - 10.1089/aid.2011.0239
M3 - Article
VL - 28
SP - 641
EP - 648
JO - AIDS Research and Human Retroviruses
T2 - AIDS Research and Human Retroviruses
JF - AIDS Research and Human Retroviruses
SN - 0889-2229
IS - 7
ER -